BrainStorm Cell Therapeutics
BCLI
#10362
Rank
$7.39 M
Marketcap
$0.67
Share price
13.56%
Change (1 day)
-71.73%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Net assets

Net assets on the balance sheet as of September 2025 : -$7.7 Million USD

According to BrainStorm Cell Therapeutics's latest financial reports the company has -$7.7 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BrainStorm Cell Therapeutics - Net assets on balance sheet (from 2002 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-$7.77 Million59.82%
2023-12-31$-$4.86 Million61.13%
2022-12-31$-$3.02 Million-115.59%
2021-12-31$$19.34 M-45.46%
2020-12-31$$35.46 M-390.14%
2019-12-31$-$12.23 Million-343.68%
2018-12-31$$5.01 M-14.69%
2017-12-31$$5.88 M-40.62%
2016-12-31$$9.9 M-29.91%
2015-12-31$$14.12 M111.66%
2014-12-31$$6.67 M143.7%
2013-12-31$$2.73 M-31.22%
2012-12-31$$3.98 M167.61%
2011-12-31$$1.48 M-424.18%
2010-12-31$-$0.46 Million-73.67%
2009-12-31$-$1.75 Million-16.04%
2008-12-31$-$2.08 Million-14.5%
2007-12-31$-$2.43 Million33.7%
2006-12-31$-$1.82 Million
2006-03-31$-$7.92 Million-1222.96%
2005-03-31$$0.7 M-2340.84%
2004-03-31$-$0.04 Million-254.42%
2003-03-31$$0.02 M-60.97%
2002-03-31$$0.05 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
$21.45 B-279,002.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-$0.53 Billion 6,673.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
$2.55 B-33,252.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$18.20 B-236,776.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-$0.29 Billion 3,550.96%๐Ÿ‡บ๐Ÿ‡ธ USA